Cargando…

Network-Based Analysis of Fatal Comorbidities of COVID-19 and Potential Therapeutics

COVID-19 is a highly contagious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The case-fatality rate is significantly higher in older patients and those with diabetes, cancer or cardiovascular disorders. The human proteins, angiotensin-converting enzyme 2 (ACE2)...

Descripción completa

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IEEE 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791434/ https://www.ncbi.nlm.nih.gov/pubmed/33891554 http://dx.doi.org/10.1109/TCBB.2021.3075299

Ejemplares similares

Cohort study of neurological comorbidities and COVID-19-related case fatality
por: Imbalzano, Gabriele, et al.
Publicado: (2021)

Neurological comorbidities and COVID-19-related case fatality: A cohort study
por: Romagnolo, Alberto, et al.
Publicado: (2021)

Fatal outcome of COVID-19 disease in a 5-month infant with comorbidities
por: Climent, Francisco José, et al.
Publicado: (2020)

Predicted COVID-19 fatality rates based on age, sex, comorbidities and health system capacity
por: Ghisolfi, Selene, et al.
Publicado: (2020)

Comorbidities, sociodemographic factors, and determinants of health on COVID-19 fatalities in the United States
por: Gerken, Jacob, et al.
Publicado: (2022)

COVID-19: Case fatality and ACE2 inhibitors treatment concerns in patients with comorbidities
por: Aghili, Rokhsareh, et al.
Publicado: (2020)

Comorbidities for fatal outcome among the COVID-19 patients: A hospital-based case-control study
por: Lu, Qing-Bin, et al.
Publicado: (2021)

COVID-19: a risk factor for fatal outcomes in patients with comorbid cardiovascular disease
por: Xu, Hui, et al.
Publicado: (2020)

Meta-analysis and adjusted estimation of COVID-19 case fatality risk in India and its association with the underlying comorbidities
por: Singh, Balbir B., et al.
Publicado: (2021)

Chronic Comorbidities in Middle Aged Patients Contribute to Ineffective Emergency Hematopoiesis in Covid-19 Fatal Outcomes
por: Romo-Rodríguez, Rubí, et al.
Publicado: (2023)

COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges
por: Pathania, Anup S., et al.
Publicado: (2021)

Potential Genes Associated with COVID-19 and Comorbidity
por: Feng, Shanshan, et al.
Publicado: (2022)

The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19
por: Callender, Lauren A., et al.
Publicado: (2020)

Comorbidities in the COVID-19 Pandemic: Scopus-Based Bibliometric Analysis
por: Fedorchenko, Yuliya, et al.
Publicado: (2023)

Potential diagnostic markers and therapeutic targets for rheumatoid arthritis with comorbid depression based on bioinformatics analysis
por: Zhou, Tao-tao, et al.
Publicado: (2023)

COVID-19 and arterial thrombosis: A potentially fatal combination
por: Moroni, Francesco, et al.
Publicado: (2021)

Infection fatality ratio and case fatality ratio of COVID-19
por: Luo, Guangze, et al.
Publicado: (2021)

Impact of Comorbidity on Fatality Rate of Patients with Middle East Respiratory Syndrome
por: Yang, Ya-Min, et al.
Publicado: (2017)

Sensitivity of comorbidity network analysis
por: Brunson, Jason Cory, et al.
Publicado: (2019)

Comorbidities and COVID-19
por: Yaddanapudi, Lakshmi Narayana
Publicado: (2020)

Global COVID-19 fatality analysis reveals Hubei-like countries potentially with severe outbreaks
por: Lv, Boyan, et al.
Publicado: (2020)

Comorbidity in lung cancer patients and its association with hospital readmission and fatality in China
por: Zhu, Dawei, et al.
Publicado: (2021)

The anatomy of COVID-19 comorbidity networks among hospitalized Korean patients
por: Shin, Eun Kyong, et al.
Publicado: (2021)

A Review on COVID-19: Primary Receptor, Endothelial Dysfunction, Related Comorbidities, and Therapeutics
por: Assareh, Elham, et al.
Publicado: (2023)

Machine learning and comorbidity network analysis for hospitalized patients with COVID-19 in a city in Southern Brazil
por: Passarelli-Araujo, Hemanoel, et al.
Publicado: (2022)

Meta-analysis on outcome-worsening comorbidities of COVID-19 and related potential drug-drug interactions
por: Awortwe, Charles, et al.
Publicado: (2020)

Peptides-based therapeutics: Emerging potential therapeutic agents for COVID-19
por: Shah, Jagat Narayan, et al.
Publicado: (2022)

GIS-Based Analysis Framework to Identify the Determinants of COVID-19 Incidence and Fatality in Africa
por: Hassaan, Mahmoud A., et al.
Publicado: (2021)

Covid-19: A Dynamic Analysis of Fatality Risk in Italy
por: Iosa, Marco, et al.
Publicado: (2020)

Alarmins, COVID-19 and comorbidities
por: Di Salvo, Eleonora, et al.
Publicado: (2021)

Comorbidities of COVID-19 Patients
por: Silaghi-Dumitrescu, Radu, et al.
Publicado: (2023)

Estimation of the case fatality rate based on stratification for the COVID-19 outbreak
por: Kim, Byungwon, et al.
Publicado: (2021)

Automated analysis of fatality rates for COVID 19 across different countries
por: Jabbar, Shaima Ibraheem
Publicado: (2021)

Dying together: A convergence analysis of fatalities during COVID-19
por: Panagiotidis, Theodore, et al.
Publicado: (2023)

Gender differences in comorbidities of patients with COVID-19: An Italian local register-based analysis
por: Agodi, Antonella, et al.
Publicado: (2023)

Biomaterial-Based Therapeutic Strategies for Obesity and Its Comorbidities
por: Li, Jing, et al.
Publicado: (2022)

Severe and fatal forms of COVID-19 in children
por: Oualha, M., et al.
Publicado: (2020)

COVID-19: Spatial analysis of hospital case-fatality rate in France
por: Souris, Marc, et al.
Publicado: (2020)

COVID 19 fatalities burden in Asian countries: An analysis of pattern and determinants
por: Panda, Prasant Kumar, et al.
Publicado: (2023)

Brain-Derived Neurotrophic Factor and Its Potential Therapeutic Role in Stroke Comorbidities
por: Liu, Wei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bvvqbdq9kson3d5p4i9gs0ji4g